Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
For over thirty-five years, available data suggested that therapeutic plasma exchange (TPE) was a useful treatment for patients with Rapidly Progressive Glomerulonephritis (RPGN) associated with ANCA Associated Vasculitis (AAV) and elevated creatinine levels. The publication of the PEXIVAS study has...
Main Authors: | Andre A. Kaplan, Wladimir M. Szpirt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Kidney and Dialysis |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-8236/2/3/35 |
Similar Items
-
Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides
by: Samy Hakroush, et al.
Published: (2024-02-01) -
Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge
by: Sanxi Ai, et al.
Published: (2022-12-01) -
Presence of anti-Glomerular basement membrane (GBM) antibodies and Myeloperoxidase anti neutrophilic cytoplasmic antibodies (MPO ANCA) in a case of rapidly progressive glomerulonephritis.
by: Gaurang P Mavani, et al.
Published: (2015-08-01) -
Etiology and outcome of rapidly progressive glomerulonephritis in children
by: Alok Kumar, et al.
Published: (2019-01-01) -
Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary
by: David Collister, et al.
Published: (2023-03-01)